Azevedo Aline, Prado Alejandro F, Antonio Raquel C, Issa Joao P, Gerlach Raquel F
Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Basic Clin Pharmacol Toxicol. 2014 Oct;115(4):301-14. doi: 10.1111/bcpt.12282. Epub 2014 Jul 25.
This MiniReview describes the essential biochemical and molecular aspects of matrix metalloproteinases (MMPs) and briefly discusses how they engage in different diseases, with particular emphasis on cardiovascular diseases. There is compelling scientific evidence that many MMPs, especially MMP-2, play important roles in the development of cardiovascular diseases; inhibition of these enzymes is beneficial to many cardiovascular conditions, sometimes precluding or postponing end-organ damage and fatal outcomes. Conducting comprehensive discussions and further studies on how MMPs participate in cardiovascular diseases is important, because inhibition of these enzymes may be an alternative or an adjuvant for current cardiovascular disease therapy.
本综述介绍了基质金属蛋白酶(MMPs)的基本生化和分子方面,并简要讨论了它们如何参与不同疾病,尤其着重于心血管疾病。有确凿的科学证据表明,许多MMPs,尤其是MMP-2,在心血管疾病的发展中起重要作用;抑制这些酶对许多心血管疾病状况有益,有时可预防或推迟终末器官损伤和致命后果。对MMPs如何参与心血管疾病进行全面讨论和进一步研究很重要,因为抑制这些酶可能是当前心血管疾病治疗的一种替代方法或辅助手段。